Skip to main content
Premium Trial:

Request an Annual Quote

Mike Brophy

Natera has appointed Mike Brophy to chief financial officer. He replaces Herm Rosenman, who had been CFO since January 2014 and resigned effective Jan. 31, 2017. Rosenman will join Natera's board of directors. Brophy had been serving as Natera's senior vice president of finance and investor relations since September 2016 and as the firm's vice president of corporate development and investor relations since September 2015. Prior to joining Natera, he was an executive director and vice president in Morgan Stanley's investment banking division. 

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.